Clinical Trials on Bipolar II in Mexico
Total 139 results
-
University of New MexicoPatient-Centered Outcomes Research Institute; Montana State University; National... and other collaboratorsTerminated
-
Laboratorios Silanes S.A. de C.V.RecruitingDyslipidemia Associated With Type II Diabetes MellitusMexico
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteNot yet recruitingDepression | Bipolar I DisorderUnited States, Canada
-
AstraZenecaCompletedAcute Bipolar DepressionBrazil, Mexico, Peru, Turkey, Argentina, Chile, Venezuela, Colombia, Guatemala
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Instituto de Seguridad y Servicios Sociales de...CompletedHypercholesterolemia, FamilialMexico
-
New Mexico VA Healthcare SystemBristol-Myers SquibbCompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Metabolic Syndrome XUnited States
-
MaineHealthRobert Wood Johnson FoundationCompletedDepression | Psychotic Disorders | Schizophrenia | Bipolar DisorderUnited States
-
ShireCompleted
-
AstraZenecaCompletedEffectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. (EMMY)Bipolar Disorder | Mania | Manic Disorder | Manic State | Bipolar Affective PsychosisMexico
-
Janssen Pharmaceutica N.V., BelgiumCompletedBipolar DisorderChina, Taiwan, Colombia, India, Malaysia, Russian Federation, South Africa, Greece, Peru, Germany, Mexico, Lebanon, Indonesia, Philippines, Jordan
-
Forest LaboratoriesGedeon Richter Ltd.CompletedDepression, BipolarUnited States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
-
AstraZenecaCompletedBipolar DisorderUnited States
-
Eli Lilly and CompanyCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderUnited States, Puerto Rico, Netherlands, Canada, Mexico
-
GlaxoSmithKlineCompletedBipolar DisorderUnited States
-
SunovionCompletedBipolar DepressionUnited States, Czech Republic, India, France, Germany, Poland, Romania, Russian Federation, South Africa, Ukraine
-
SunovionCompletedBipolar DepressionUnited States, Czech Republic, India, France, Romania, Russian Federation, South Africa, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedBipolar DisorderUnited States, Mexico, Peru, South Africa, Russian Federation, Croatia, Bulgaria
-
Eli Lilly and CompanyCompletedSchizophrenia | Bipolar DisorderRussian Federation, United States, Puerto Rico
-
US Department of Veterans AffairsCompletedSchizophrenia | Bipolar DisorderUnited States
-
AstraZenecaCompletedBipolar DepressionUnited States, Mexico, Taiwan, South Africa, Serbia, India, Colombia
-
AstraZenecaCompletedDepression | Bipolar Disorder | Bipolar DepressionUnited States, Peru, South Africa, Turkey, Romania, Australia, Chile, Greece, Mexico, Colombia, Costa Rica
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedBipolar Disorder | Bipolar ManiaUnited States, Chile, Guatemala, Taiwan, Spain, Italy, France, Hong Kong, India, Mexico, Venezuela, Russian Federation, Germany
-
SunovionCompletedSchizophrenia | Bipolar Depression | AutismKorea, Republic of, United States, Malaysia, Bulgaria, Poland, Mexico, Colombia, France, Hungary, Philippines, Puerto Rico, Romania, Russian Federation, Spain, Ukraine
-
TakedaTerminatedBipolar DisorderUnited States, Argentina, Chile, Colombia, Mexico
-
SunovionCompletedBipolar DepressionUnited States, Canada, Czech Republic, India, Lithuania, Peru, South Africa, France, Poland, Romania, Russian Federation, Ukraine, Colombia, Slovakia, Japan
-
AstraZenecaCompletedBipolar DisorderUnited States, Bulgaria, Peru, Russian Federation, Philippines, Malaysia, Lithuania, Romania, Ukraine, Argentina, Taiwan, Mexico, Thailand, India, Colombia
-
AstraZenecaCompletedHypertriglyceridemia | Hyperlipidemia | Hyperlipoproteinemia Type V | Hyperlipoproteinemia Type IV | Hyperlipoproteinemia Type IIbMexico
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedBipolar DisorderUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedBipolar DisorderUnited States
-
Instituto Nacional de Cancerologia de MexicoCompletedPhase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIMexico
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedBipolar DisorderUnited States, Canada
-
University of New MexicoUniversity of Pittsburgh; Dialysis Clinic, Inc.TerminatedHypertension | Proteinuria | Type II DiabetesUnited States
-
Alkermes, Inc.Enrolling by invitationSchizophrenia | Bipolar I DisorderUnited States, Argentina, Brazil, Colombia, Mexico
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedBipolar I DisorderUnited States
-
ShireCompletedHunter SyndromeUnited States, Spain, Canada, United Kingdom, Mexico, Australia, France
-
Alkermes, Inc.RecruitingSchizophrenia | Bipolar I DisorderUnited States, Argentina, Mexico, Brazil, Colombia
-
ShireCompletedHunter SyndromeSpain, United States, Canada, United Kingdom, France, Australia, Mexico
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaSlovenia, Taiwan, Russian Federation, Canada, Netherlands, Brazil, Denmark, Mexico, Spain, Turkey
-
SunovionCompletedBipolar I DepressionUnited States, Korea, Republic of, Bulgaria, Poland, Mexico, Puerto Rico, Colombia, Hungary, France, Philippines, Ukraine
-
Merck Sharp & Dohme LLCCompletedHypercholesterolemia | Familial HypercholesterolemiaUnited States, Germany, Japan, Korea, Republic of, Mexico, Norway, Turkey, United Kingdom
-
CENTOGENE GmbH RostockTerminatedMucopolysaccharidosis II | Hunter Syndrome | Hunter's Syndrome, Mild Form | Hunter's Canal SyndromeMexico
-
ShireCompletedHunter Syndrome | Mucopolysaccharidosis (MPS)United States, Argentina, Mexico, Spain, United Kingdom
-
AstraZenecaCompletedAlcohol Dependence | Bipolar I DisorderUnited States
-
Forest LaboratoriesCompletedBipolar 1 DisorderUnited States, Bulgaria, Croatia, India, Philippines, Romania, Russian Federation, Serbia, Turkey, Ukraine
-
Bristol-Myers SquibbCompletedDiabetes Mellitus IIUnited States, Italy, Spain, Argentina, Brazil, Mexico, Netherlands, Puerto Rico, Canada, Sweden, Australia, Poland, France, United Kingdom, Czech Republic, South Africa
-
Medtronic Cardiac Rhythm and Heart FailureRecruitingHeart Failure NYHA Class II | Heart Failure NYHA Class IIIUnited States
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico